Results 191 to 200 of about 291,220 (220)

Studies of platelet antibodies at MacKay Memorial Hospital in Taiwan: Methods, case reviews and a possible case of post-transfusion purpura. [PDF]

Vox Sang
Chen-Yu C, Hsiao-Lin C, Yung-Shu C, Wern-Cherng C, Marie L.   +4 more
europepmc   +1 more source

A Diagnostic Challenge: Severe Thrombocytopenia During Streptococcal Cellulitis Revealing Previously Unrecognized Immune Thrombocytopenia. [PDF]

Cureus
Izadian Bidgoli A, Gomez Usatorres A, Gomez Usatorres HA, Gomez Veliz A.   +3 more
europepmc   +1 more source

Macrophages are key mediators of platelet refractoriness. [PDF]

Blood Adv
Pelham-Webb B, Stone EF.
europepmc   +1 more source

Editorial: New frontiers in safeguarding blood component transfusions: innovative approaches to bacterial risk reduction. [PDF]

Front Med (Lausanne)
Zhou YY, Fontaine MJ, Vasovic LV, Maitta RW.   +3 more
europepmc   +1 more source

IL-8 and sCD40L predict platelet refractoriness and survival of pediatric patients with solid tumors receiving chemotherapy. [PDF]

BMC Cancer
Zhou C, Chen X, Xu J, Ma J, Lin J, Wang H.   +5 more
europepmc   +1 more source

Hemostatic rescue with rFVIIa in Bernard-Soulier syndrome refractory to HLA-matched platelet transfusion. [PDF]

Ann Hematol
Okamoto Y, Mizumoto C, Yamashita K, Inoue S, Saito S, Morimoto N, Takaori-Kondo A.   +6 more
europepmc   +1 more source

Targeting macrophages prevents alloantibody-mediated platelet clearance in a murine model of transfusion refractoriness. [PDF]

Blood Adv
Rojas-Jiménez G, Angénieux C, Proamer F, Eckly A, Maître B.   +4 more
europepmc   +1 more source

Immune-mediated platelet refractoriness: Mechanisms, diagnostics, and therapeutic breakthroughs. [PDF]

Transfus Med
Ma L, Wu L, Xie J.
europepmc   +1 more source